HCPCS J1576 is officially defined as "Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg." HCPCS J1576 is referenced in 2 tracked payer policy changes from Florida Blue and Alaska Medicaid. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J1576 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.